Log in
(Ad)
Custom-design an options strategy to fit your market outlook bullish, bearish or neutral or your outlook on market volatility. This guide goes beyond the basics to help you understand how to evaluate a strategy's risk as well as its reward. Start with your market outlook. Then hone in on your strategy based on the risk you're willing to take and the potential reward..

NASDAQ:SLDB - Solid Biosciences Stock Price, Forecast & News

$3.75
-0.11 (-2.85 %)
(As of 01/22/2020 01:28 AM ET)
Add
Compare
Today's Range
$3.68
Now: $3.75▼
$3.88
50-Day Range
$3.59
MA: $4.19▼
$4.77
52-Week Range
$2.75
Now: $3.75▼
$26.70
Volume434,992 shs
Average Volume693,976 shs
Market Capitalization$172.46 million
P/E RatioN/A
Dividend YieldN/A
Beta1.39
Solid Biosciences Inc, a life science company, engages in identifying and developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, an adeno-associated viral vector-mediated gene transfer, which is in a Phase I/II clinical trial to restore functional dystrophin protein expression in patients' muscles. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SLDB
Previous Symbol
CUSIPN/A
CIK1707502
Webhttp://www.solidbio.com/
Phone617-337-4680

Debt

Debt-to-Equity Ratio0.05
Current Ratio6.78
Quick Ratio6.78

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book Value$3.53 per share
Price / Book1.06

Profitability

EPS (Most Recent Fiscal Year)($2.25)
Net Income$-74,800,000.00
Net MarginsN/A
Return on Equity-105.82%
Return on Assets-88.93%

Miscellaneous

Employees111
Outstanding Shares45,988,000
Market Cap$172.46 million
Next Earnings Date3/11/2020 (Estimated)
OptionableOptionable

Receive SLDB News and Ratings via Email

Sign-up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter.

NASDAQ:SLDB Rates by TradingView

(Ad)

Simple Options Trading for Beginners retails on Amazon for $19.95 and has 4 out of 5 stars. It was written by a stock market trading veteran with over 44 years of experience. Because of a special promotion, this book is 100% FREE for you today.

Solid Biosciences (NASDAQ:SLDB) Frequently Asked Questions

What is Solid Biosciences' stock symbol?

Solid Biosciences trades on the NASDAQ under the ticker symbol "SLDB."

How were Solid Biosciences' earnings last quarter?

Solid Biosciences Inc (NASDAQ:SLDB) announced its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.63) by $0.04. View Solid Biosciences' Earnings History.

When is Solid Biosciences' next earnings date?

Solid Biosciences is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Solid Biosciences.

What price target have analysts set for SLDB?

8 brokerages have issued 12 month price targets for Solid Biosciences' shares. Their forecasts range from $2.00 to $22.00. On average, they expect Solid Biosciences' stock price to reach $9.86 in the next year. This suggests a possible upside of 162.9% from the stock's current price. View Analyst Price Targets for Solid Biosciences.

What is the consensus analysts' recommendation for Solid Biosciences?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Solid Biosciences in the last year. There are currently 2 sell ratings, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Solid Biosciences.

Has Solid Biosciences been receiving favorable news coverage?

Media stories about SLDB stock have trended negative recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Solid Biosciences earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Solid Biosciences.

Are investors shorting Solid Biosciences?

Solid Biosciences saw a decrease in short interest during the month of December. As of December 13th, there was short interest totalling 3,440,000 shares, a decrease of 5.2% from the November 28th total of 3,630,000 shares. Based on an average daily volume of 1,190,000 shares, the short-interest ratio is currently 2.9 days. Currently, 11.4% of the shares of the stock are short sold. View Solid Biosciences' Current Options Chain.

Who are some of Solid Biosciences' key competitors?

What other stocks do shareholders of Solid Biosciences own?

Who are Solid Biosciences' key executives?

Solid Biosciences' management team includes the folowing people:
  • Dr. Andrey Juan Zarur, Co-Founder & Chairman of Directors (Age 48)
  • Mr. Ilan Ganot, Co-founder, Pres, CEO & Director (Age 45)
  • Mr. Pedro Alvaro Amorrortu, Chief Operating Officer (Age 47)
  • Dr. Carl Ashley Morris, Chief Scientific Officer (Age 49)
  • Dr. Andrey Zarur Ph.D., Co-Founder & Chairman of Directors (Age 48)

When did Solid Biosciences IPO?

(SLDB) raised $130 million in an initial public offering on Friday, January 26th 2018. The company issued 7,000,000 shares at $18.00-$19.00 per share. J.P. Morgan, Goldman Sachs and Leerink Partners acted as the underwriters for the IPO and Nomura and Chardan were co-managers.

How do I buy shares of Solid Biosciences?

Shares of SLDB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Solid Biosciences' stock price today?

One share of SLDB stock can currently be purchased for approximately $3.75.

How big of a company is Solid Biosciences?

Solid Biosciences has a market capitalization of $172.46 million. The company earns $-74,800,000.00 in net income (profit) each year or ($2.25) on an earnings per share basis. Solid Biosciences employs 111 workers across the globe.View Additional Information About Solid Biosciences.

What is Solid Biosciences' official website?

The official website for Solid Biosciences is http://www.solidbio.com/.

How can I contact Solid Biosciences?

Solid Biosciences' mailing address is 141 PORTLAND STREET FIFTH FLOOR, CAMBRIDGE MA, 02139. The company can be reached via phone at 617-337-4680.


MarketBeat Community Rating for Solid Biosciences (NASDAQ SLDB)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  201 (Vote Outperform)
Underperform Votes:  184 (Vote Underperform)
Total Votes:  385
MarketBeat's community ratings are surveys of what our community members think about Solid Biosciences and other stocks. Vote "Outperform" if you believe SLDB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLDB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Featured Article: Price-Sales Ratio
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel